At some point as the milestones get ticked off, the risk will come down to a known level and then the bigger institutions will want to get involved. That is when the share price will really fly.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress